Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. William Gradishar

Breast Oncology · NU

View

Dr. Jame Abraham

Breast Oncology · Cleveland Clinic

View

Dr. Azka Ali

Breast Oncology · Cleveland Clinic Lerner

View

Dr. Amy Comander

Breast Oncology · PHS

View

Dr. Anastasia Martynova

Breast Oncology · USC

View

Dr. Rani Bansal

Breast Oncology · Duke

View

Dr. Gilbert Bader

Breast Oncology · OSUMC

View

Dr. VK Gadi

Breast Oncology · UI Health

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    PTDr. Paolo Tarantino
    Leading Voice

    Dr. Paolo Tarantino

    Hematology & Oncology · Breast Oncology
    Dana-Farber Cancer Institute
    drpaolotarantino
    Boston, MA

    Research

    ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors

    2026

    Via Radiother Oncol

    Research

    Different Diseases, Different Escapes: Trastuzumab Deruxtecan Resistance in HER2-Amplified versus HER2-Low Breast Cancer

    2026

    Via Cancer Discov

    Research

    Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancer

    2026

    Via NPJ Breast Cancer

    Research

    Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer

    2026

    Via NPJ Precis Oncol

    Research

    PEACE: Development and Validation of a Brief Five-Item Sleep Quality Scale for Community and Primary Care

    2026

    Via Medicina (Kaunas)

    Research

    Oral selective estrogen receptor degraders in hormone receptor-positive, HER2-negative advanced breast cancer: a systematic review and meta-analysis

    2026

    Via Breast Cancer Res Treat

    Research

    Serum copper, rubidium, selenium, strontium, and zinc and psychophysical health in adults of the Sarno river Basin: PREVES-STOP 2025 community biomonitoring results

    2026

    Via J Basic Clin Physiol Pharmacol

    Research

    SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer

    2026

    Via NPJ Breast Cancer

    Research

    Rise and Fall of Neoadjuvant Carboplatin for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

    2026

    Via J Clin Oncol

    Research

    Real-world postprogression outcomes after first-line treatment with ribociclib plus aromatase inhibitor versus aromatase inhibitor alone in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast ca

    2026

    Via ESMO Open

    Research

    Recurrence risk in HR-positive/HER2-negative early breast cancer: real-world US electronic health records study

    2026

    Via J Natl Cancer Inst

    Research

    Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2-Positive Breast Cancer: A Secondary Analysis of the DAPHNe Trial

    2026

    Via JAMA Oncol

    Research

    Development and validation of a human-supervised AI-augmented living oncology evidence platform: a breast cancer pilot study

    2026

    Via ESMO Real World Data Digit Oncol

    Research

    Treatment Effect Discrepancy Between PFS and OS in Antibody-Drug Conjugate Trials for Metastatic Breast Cancer: A Meta-Epidemiologic Analysis

    2026

    Via J Natl Cancer Inst

    Research

    Reply to: "Creatinine Assay Methods and Carboplatin Dosing Transparency in the neoCARHP Trial"

    2026

    Via J Clin Oncol